A comprehensive view of Approved Drugs / Devices. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Hipra's Bimervax COVID-19 vaccine set to enter EU market; vaccine is cheaper and easier to distribute than Pfizer, touts fewer side effects, has longer-lasting effectiveness, and compatibility with lower distribution temperatures
Published: March 31, 2023 by CE Noticias Financieras (Latin America)
FDA approves Abbott's Epic Max stented tissue valve for aortic regurgitation or stenosis treatment; the device offers improved blood flow and a low-profile frame for potential future interventions
Published: March 31, 2023 by ENP Newswire
FDA approves Narcan nasal spray for OTC use to combat opioid overdoses; over 100,000 reported fatal overdoses driven by synthetic opioids prompt nonprescription access to life-saving medication.
Published: March 30, 2023 by U.S. Food and Drug Administration (FDA)
Bristol Myers Squibb receives European Commission approval of Sotyktu deucravacitinib oral treatment for adults with moderate-to-severe plaque psoriasis; psoriasis affects about 14 million people in Europe, with 25% having moderate-to-severe cases
Published: March 28, 2023 by Bristol-Myers Squibb Co.
FDA approves Regeneron’s Evkeeza evinacumab-dgnb as an adjunct to other lipid-lowering therapies for children aged 5 to 11 with homozygous familial hypercholesterolemia; HoFH is an ultra-rare inherited condition that affects about 1,300 people in the US
Published: March 22, 2023 by Regeneron Pharmaceuticals Inc.

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count